Nalaganje...
Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China
PURPOSE: Agents that inhibit sodium glucose co-transporter 2 (SGLT2), including canagliflozin and dapagliflozin, become available for the treatment of Chinese patients with type 2 diabetes mellitus (T2DM). This study assessed the economic outcomes of canagliflozin 100 mg versus dapagliflozin 10 mg i...
Shranjeno v:
| izdano v: | Front Pharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6521739/ https://ncbi.nlm.nih.gov/pubmed/31143117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00480 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|